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The first Japanese patient with mandibular hypoplasia,
deafness, progeroid features and lipodystrophy diagnosed via
POLD1 mutation detection
Asami Okada1,5, Tomohiro Kohmoto2,5, Takuya Naruto2, Ichiro Yokota1,3, Yumiko Kotani1, Aki Shimada3,4, Yoko Miyamoto2,
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Mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome is a rare autosomal dominant disorder
caused by heterozygous POLD1mutations. To date, 13 patients affected by POLD1mutation-caused MDPL have been described. We
report a clinically undiagnosed 11-year-old male who noted joint contractures at 6 years of age. Targeted exome sequencing
identified a known POLD1 mutation [NM_002691.3:c.1812_1814del, p.(Ser605del)] that diagnosed him as the first Japanese/East
Asian MDPL case.
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Mandibular hypoplasia, deafness, progeroid features and lipody-
strophy (MDPL, MIM#615381) syndrome is a rare autosomal
dominant systemic disorder resulting from heterozygous muta-
tions in POLD1 (MIM#174761).1–3 MDPL is clinically characterized
by prominent loss of subcutaneous fat, characteristic facial
appearance, metabolic abnormalities involving insulin resistance
and diabetes mellitus, and sensorineural deafness occurring late in
the first or second decades of life. To date, 18 patients affected by
this syndrome have been described, including 1 Indian, 2 Hispanic
and 15 Caucasians.1,2,4–6 Among the 13 POLD1 mutation-caused
MDPL cases, all have been caused by one of two different POLD1
mutations: an in-frame deletion (Ser605del, 11 cases) and a
missense mutation (R507C, 2 cases).2,4–6 In most of these cases,
the mutation occurred de novo.2,4–6 Although these POLD1
mutations appear to occur in genic hotspots regardless of race/
ethnicity, no East Asian cases (including Japanese) have been
reported.
We herein report the first Japanese/East Asian case of MDPL in
an 11-year-old male with characteristics of MDPL. We used
targeted exome sequencing (TES) as a genome-first approach in a
clinically undiagnosed Japanese patient and determined that he
was carrying a known heterozygous POLD1 mutation.
The patient was an 11-year-old, first-born male child of healthy,
nonconsanguineous Japanese parents with unremarkable family
history (Figure 1a). He was born through normal vaginal delivery
at full term with birth weight of 2.692 kg (−0.8 s.d.), body length of
46.6 cm (−1.1 s.d.) and occipitofrontal circumference of 33.2 cm
(−0.1 s.d.). His early developmental milestones were normal, but
his parents noticed poor height and weight gain when he was 3
years of age. At 6 years of age, school teachers noticed that he was
unable to either perform kicking motions while swimming or sit
on his heels, and an orthopedist pointed out the presence of joint
contractures. At 7 years of age, he was referred to a pediatric
endocrinology department due to his short stature. He presented
with prominent eyes, beaked nose, mandibular hypoplasia,
crowded teeth, small mouth and testicular hypoplasia. He was
also diagnosed with moderate sensorineural bilateral hearing loss
and he started to wear hearing aids. Growth hormone (GH) levels
in a GH stimulation test were observed to be normal. Standard
karyotyping using peripheral blood revealed no abnormalities (46,
XY). No results consistent with known metabolic syndromes were
obtained from metabolic surveys, including serum amino acids
and urine organic acids. At 9 years of age, tight skin around his
cheeks, hepatic steatosis and mild liver dysfunction were noted. At
the age of 11, due to his short stature (weight; 24.6 kg (−1.7 s.d.),
height; 125.2 cm (−2.9 s.d.) and body mass index; 15.7), facial
features, deafness, primary hypogonadism, joint contractures and
thin arms and legs with a wide trunk, the patient visited a division
of clinical genetics to consider any genetic diseases (with
informed consent from his parents). Although the patient’s clinical
features were retrospectively consistent with the recently
proposed clinical spectrum of MDPL caused by POLD1 mutations
(Table 1),1,2,4–6 the patient remained undiagnosed. As a result, TES
was considered using a panel of multiple potential disease-
causing genes.
After informed consent was obtained from the parents,
molecular diagnosis was performed using genomic DNA extracted
from the patient’s blood sample. The study was approved by the
ethics committees of Tokushima University. To screen known
disease-associated genes for molecular diagnosis, we used a
TruSight One Sequencing Panel (Illumina, San Diego, CA, USA)
with a MiSeq sequencer (Illumina), followed by our pipeline for
next generation sequencing (NGS) data analysis as previously
described,7,8 with a minor modification due to a software update
specific for a bioinformatics pipeline.8 To identify presumably
pathogenic single-nucleotide variants, we excluded sequence
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variants with low-allele frequencies, that is, 40.01 included in the
1000 Genomes Project database (http://www.1000genomes.org),
National Heart, Lung, and Blood Institute Grand Opportunity
Exome Sequencing Project (ESP6500, http://evs.gs.washington.
edu/EVS), Human Genetic Variation Database (http://www.gen
ome.med.kyoto-u.ac.jp/SnpDB) and integrative Japanese Genome
Variation Database (https://ijgvd.megabank.tohoku.ac.jp). Copy-
number variations analysis using TES data was also performed as
described elsewhere.8,9 These analyses detected an in-frame
heterozygous deletion in exon 15 of POLD1, NM_002691.3
(POLD1_v001):c.1812_1814del, affecting the polymerase-active
site, NM_002691.3(POLD1_i001):p.(Ser605del), which was con-
firmed by Sanger sequencing (Figure 1b). This mutation has been
shown to cause most cases of MDPL.2,6 No other variants or gross
deletions were detected in the coding regions of other progeroid-
related genes (data not shown). As a result of this molecular
diagnosis and the re-evaluation of the affected patient’s clinical
features, together with the clinical spectrum of patients harboring
POLD1 mutations (Table 1),1,2,4–6 the patient was diagnosed with
MDPL caused by a known frameshift deletion in POLD1. Because
parental DNA was not available, we were unable to determine if
the mutation occurred de novo.
To the best of our knowledge, the patient described herein is the
19th MDPL and the 14th POLD1 mutation-caused MDPL case
reported worldwide. Notably, this patient is the first Japanese or East
Asian case with MDPL, which is caused by the most common POLD1
in-frame deletion mutation (c.1812_1814del). Our case supports the
hypothesis that POLD1 mutations causing MDPL, at least this in-
frame deletion mutation, commonly occur at hotspots irrespective
of race/ethnicity. The CTCCT motif occurs within two CTC triples, one
of which is deleted in most MDPL cases, and corresponds to the
complement of the mirror image of the ‘deletion hotspot consensus
sequences’ TG(A/G) (A/G) (G/T) (A/C).10,11 In addition, (A/T)GGAG is
one of the specific native DNA sequences known to arrest DNA
synthesis by DNA polymerase α.12 Therefore, the arrest of DNA
synthesis at this DNA polymerase pause site may increase the
possibility that a slipped mispairing was mediated by direct repeats
and/or secondary structure formation promoted by symmetric
elements and might cause the commonly observed c.1812_1814del
mutation in POLD1 in MDPL patients.5,11
Although clinical characteristics of the patient, including his
phenotype, history of the disease and metabolic profile showed
features fully and retrospectively compliant with the diagnosis of
MDPL (Table 1),1,2,4–6 clinical diagnosis could not be evoked
because of the rarity of this disease. Indeed, reported MDPL cases
are clinically and/or genetically diagnosed at a relatively higher
age (median age 420 years).1,2,4–6 By facilitating differential
diagnosis of this syndrome and related diseases in a cost-effective
manner, molecular diagnosis by a genome-first approach may be
crucially important for providing appropriate therapeutic options
and optimized health care in patients with unclassified segmental
progeroid syndromes.5 In addition, correct diagnosis through this
approach also can be useful in establishing recurrence risks and
for providing appropriate genetic counseling to the family.
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Figure 1. (a) Family pedigree; arrow shows the proband (P).
(b) Partial sequence chromatograms around codon 605 on exon
15 of POLD1 in the patient. The red box denotes the deleted bases.
The DNA and corresponding amino acid sequences of the wild-type
and mutant POLD1 alleles are also shown.
Table 1. Clinical characteristics of the POLD1 mutation-caused MDPL
patient presented here compared to previously described subjects
Clinical features Study patient Previous studiesa
(n= 13)
Age (years; range, median) 11 10–62, 25
Sex Male 6 males, 7 females
Birth weight (kg; range, mean) 2.692 2.4–4.2, 3.23
(n= 9)
Height (cm) 125.2 —
Weight (kg) 24.58 —
BMI (kg/m2; range, mean) 15.7 13.8–26.8, 17.5
Metabolic profile
Diabetes mellitus N 5/13
Hepatic steatosis Y 4/6
ALT (U/l) 52 (5–40) Abnormal LFT 5/8
Total cholesterol (mg/dl) 141 (130–220) High 8/10
Triglycerides (mg/dl) 125 (35–150) High 9/11
Leptin (ng/ml) 10.9 4.4–8.2, 5.6 (n= 4)
Morphology
Short stature Y 8/13
Tight skin around cheeks and small nasal
bones
Y 13/13
Mandibular underdevelopment Y 12/13
Dental overcrowding/irregular teeth Y 10/13
Telangiectasia N 9/13
Thin arms and legs with wide trunk Y 13/13
High pitched voice Y 9/12
Hearing impairment Y 10/13
Musculoskeletal
Joint contractures Y 5/13
Muscle wasting Y 11/13
Kyphosis/scoliosis N 4/5
Hypogonadism Y 4/5 males
Abnormal cognitive function N 1/12
Abbreviations: ALT, alanine aminotransferase; BMI, body mass index; LFT,
liver function test; MDPL, mandibular hypoplasia, deafness, progeroid
features and lipodystrophy; N, no; Y, yes.
aPreviously reported cases with POLD1 mutation-caused MDPL.
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